Pre header text goes here. Will show on inbox
To view this email as a web page, click here.

 
ADVERTISEMENT
Ad description here
 
COMMUNITY REPORT
 
Thursday is Best Day to Visit a Pharmacy
Did you know that your patients are most likely to be happiest on a Thursday and most likely to be angriest on a Sunday? Read all this and more from a new study by HappyOrNot, which can help you improve your customer satisfaction rates.
Read more
 
ADVERTISEMENT
 
POPULAR ON THE WEB
 
Walmart Pharmacy Adds Express Lanes to Its App
New express lanes are designed to make it easier for customers to quickly fill their prescriptions.
 
Small Doses: The News You Need to Be the Best
Bite-sized doses of the news you need to stay ahead.
 
Pfizer Receives FDA Warning Letter
In a letter from the FDA made public on February 28, a Pfizer plant in McPherson, KS, was accused of ignoring various complaints and safety procedures.
 
EDITOR'S CHOICE
 
BD Targets Opioid Control IV Safety Med Availability
With the goal of helping to advance the safe and efficient management of medication across the continuum of care, BD (Becton, Dickinson and Company) has unveiled the establishment of the BD Institute for Medication Management Excellence.
Read more
 
INSIDE THE LATEST ISSUE
 
Meeting the Pharmacy Needs of Tourists, Vacationers, and Travelers
image description here What happens when people lose or forget their drugs while traveling? Disney may have an answer.

 
CONTINUING EDUCATION
 
Human papillomavirus (HPV) vaccine: Updated recommendations and strategies to improve
New Options When Statins Are Not Enough
Key cogs in the management of Parkinson's disease
 
DIGITAL EDITION
 
February 2017 | Vol. 161 No. 2
In this issue, find out what a Trump administration could mean for you, and take another look at specialty pharmacy before it's too late. We also take a look at the importance of standardization and discuss food interactions.

Read the whole issue here
 
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.